Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1.
- Author:
Chenxi GAO
1
;
Jinming SHI
1
;
Jingxin ZHANG
2
;
Yin LI
3
;
Yi ZHANG
4
Author Information
- Publication Type:Journal Article
- MeSH: B7-H1 Antigen/biosynthesis*; Cell Proliferation/drug effects*; Chemokines/biosynthesis*; Female; Humans; Ovarian Neoplasms/pathology*; Survival Rate; Up-Regulation
- From: Journal of Zhejiang University. Science. B 2022;23(2):164-170
- CountryChina
- Language:English
- Abstract: Ovarian cancer is the third-most-common malignant reproductive tumor in women. According to the American Cancer Society, it has the highest mortality rate of gynecological tumors. The five-year survival rate was only 29% during the period from 1975 to 2008 (Reid et al., 2017). In recent decades, the five-year survival rate of ovarian cancer has remained around 30% despite continuous improvements in surgery, chemotherapy, radiotherapy, and other therapeutic methods. However, because of the particularity of the volume and location of ovarian tissue, the early symptoms of ovarian cancer are hidden, and there is a lack of highly sensitive and specific screening methods. Most patients have advanced metastasis, including abdominal metastasis, when they are diagnosed (Reid et al., 2017). Therefore, exploring the mechanism of ovarian cancer metastasis and finding early preventive measures are key to improving the survival rate and reducing mortality caused by ovarian cancer.
